###begin article-title 0
Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 241 249 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">children</span>
PspA is recognized as a major pneumococcal virulence factor and a possible vaccine candidate. The aim of this study was to analyze the PspA family and clade distribution among 112 Spanish pneumococci representatives of dominant clones among patients with invasive disease (n = 66) and nasopharyngeal healthy carriage in children (n = 46).
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 525 527 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6B</sup>
###xml 539 541 539 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 571 572 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 587 589 587 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 606 607 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 655 658 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23F</sup>
###xml 670 672 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9V</sup>
###xml 689 691 689 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 709 710 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 732 734 732 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7F</sup>
###xml 778 781 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15A</sup>
###xml 799 802 799 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18C</sup>
###xml 819 821 819 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">21</sup>
PspA family 2 was predominant among invasive (63.6%) and carriage (54.3%) pneumococcal isolates. No PspA family 3 isolates were detected and only one strain was PspA negative. Although four clonal complexes contained strains of different clades, a clear association between clade and multi locus sequence typing results was found. Clades 1, 3 and 4 were associated with a wide variety of sequence types (ST) related to multiresistant and antibiotic-susceptible worldwide-disseminated clones. Clade 1 was associated with Spain6B-ST90, Spain14-ST18, Colombia5-ST289, Sweden1-ST306, Denmark14-ST230 and Sweden1-ST304 clones. Clade 3 was associated with Spain23F-ST81, Spain9V-ST156, Tennessee14-ST67, Netherlands3-ST180 and Netherlands7F-ST191 clones. Clade 4 was related to Sweden15A-ST63, Netherlands18C-ST113 and Greece21-ST193 clones. In contrast, PspA clade was not related to serotype, age or clinical origin of the isolates.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">children</span>
PspA clades were associated with genotypes. PspA family 2 and family 1 were dominant among major Spanish pneumococcal clones isolated from patients with invasive disease and nasopharyngeal carriage in children.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 249 263 249 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae </italic>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 0 24 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 142 150 <span type="species:ncbi:9606">children</span>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
###xml 249 262 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 300 308 <span type="species:ncbi:9606">children</span>
Streptococcus pneumoniae is a major cause of serious community-acquired diseases (such as pneumonia, bacteremia or meningitis), especially in children, the elderly, and among patients with immunological disorders [1]. Nasopharyngeal colonization by S. pneumoniae is highly common, particularly among children attending day-care centers and in adults in long-term institutions [2].
###end p 8
###begin p 9
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 641 642 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 359 367 <span type="species:ncbi:9606">children</span>
###xml 433 441 <span type="species:ncbi:9606">children</span>
###xml 536 544 <span type="species:ncbi:9606">children</span>
###xml 920 928 <span type="species:ncbi:9606">children</span>
Pneumococci are presently divided into 91 serotypes, which are defined by differences in their polysaccharide capsule [3,4]. Two serotype-based vaccines are currently available: the 23-valent polysaccharide vaccine (23V-PSV) which has been shown to be effective in the elderly [5-7], and the heptavalent pneumococcal conjugate vaccine (PCV7) which is used in children below the age of two [5]. In the USA the introduction of PCV7 in children was associated with a decrease in the incidence of invasive pneumococcal diseases (IPD) among children and adults [8]. Moreover, a decrease in IPD caused by resistant strains has also been observed [9]. Although current IPD rates are lower than those observed in the pre-vaccine period, recent reports have shown an increase in IPD caused by non-vaccine serotypes in the USA [10]. In Spain, since the introduction of PCV7, IPD rates due to PCV7 serotypes have decreased in both children and adults, but this improvement has been counterbalanced by an increase in IPD due to non-PCV7 serotypes [11,12].
###end p 9
###begin p 10
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1059 1061 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1097 1100 1093 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psp</italic>
###xml 1446 1448 1442 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 717 723 <span type="species:ncbi:9606">humans</span>
Currently, two new conjugated vaccines are under development - 10-valent and the 13-valent vaccines, which both contain some emerging serotypes [13]. Alternative vaccines are also being evaluated, such as those based on pneumococcal virulence proteins. Many pneumococcal proteins have been investigated as vaccine candidates, for instance, pneumolysin, PsaA, PspC, and PspA [13,14]. The pneumococcal surface protein A (PspA) is an important virulence factor which interferes with complement deposition on the pneumococcal surface [15] and is detected in almost all pneumococci [16-18]. It is highly immunogenic and protective and has proved to be highly cross-reactive both in various animal models [15,19,20] and in humans [21]. It is hypothesized that a PspA-based vaccine could protect against invasive disease and also eliminate the carrier state [15-22]. PspA is constituted by five domains: a signal peptide, a alpha-helical charged domain which includes a clade-defining region, a proline-rich region, a choline-binding domain and a C-terminal domain [16]. Although the PspA encoding gene (pspA) is highly genetically variable, the classification by families is based on nucleotide and amino acid identity. Each of the three PspA families is subdivided into different clades: family 1 is composed by two clades (clade 1 and 2), family 2 comprises three clades (clades 3, 4 and 5), and PspA family 3 has only one divergent clade (clade 6) [16].
###end p 10
###begin p 11
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 180 188 <span type="species:ncbi:9606">children</span>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
The aim of this study was to analyze the distribution of the PspA clades among a pneumococcal collection representative of major clones found in two previous studies among healthy children carriers [23] and patients with invasive disease [11].
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Bacterial strains
###end title 13
###begin p 14
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sma</italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
One hundred and twelve pneumococcal strains previously characterized by pulsed field gel electrophoresis (PFGE) with SmaI restriction enzyme, as described elsewhere [24] and serotyped by Quellung reaction [25], were selected as follows:
###end p 14
###begin p 15
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 245 253 <span type="species:ncbi:9606">patients</span>
a) Forty-nine pneumococci isolated from adults with IPD in Barcelona (NorthEast of Spain) between 1997 and 2007 (Additional file 1). These 49 strains were representative of the 32 major genotypes found among 968 pneumococci causing IPD in adult patients in Barcelona [11]. The pneumococcal strains selected were isolated from blood (n = 36), CSF (n = 11) and other sterile fluids (n = 2);
###end p 15
###begin p 16
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
b) Seventeen pneumococci isolated from patients with IPD in Oviedo (Northern Spain) in 2004-2005 (Additional file 1) selected as representative of the nine major PFGE patterns among 101 consecutive invasive strains (unpublished data). The selected strains were isolated from blood (n = 11), CSF (n = 3) and other sterile fluids (n = 3);
###end p 16
###begin p 17
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 267 275 <span type="species:ncbi:9606">children</span>
c) Forty-six pneumococci were selected from nasopharyngeal carriers aged from 1 to 4 years old, in Oviedo (Northern Spain) in 2004-2005 [23] (Additional file 1). These strains were representative of 29 dominant PFGE patterns found among 365 pneumococci isolated from children attending 23 day-care centers.
###end p 17
###begin title 18
Antimicrobial susceptibility testing
###end title 18
###begin p 19
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 304 318 304 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae </italic>
###xml 304 317 <span type="species:ncbi:1313">S. pneumoniae</span>
The minimal inhibitory concentration (MIC) was determined by microdilution following CLSI guidelines [26] using a panel of antimicrobials which included penicillin, erythromycin, clindamycin, tetracycline, chloramphenicol and cotrimoxazol. Resistant strains were defined according to CLSI criteria [27]. S. pneumoniae ATCC 49619 was used as control.
###end p 19
###begin title 20
Multilocus sequence typing (MLST) and eBURST
###end title 20
###begin p 21
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
MLST was performed as described previously [28]. The allele's number and sequence types (ST) were assigned using the pneumococcal MLST website [29]. Lineage assignment was achieved by eBURST analysis [30,31].
###end p 21
###begin title 22
PspA detection
###end title 22
###begin p 23
###xml 87 88 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 182 186 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq </italic>
###xml 215 218 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 441 443 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 497 499 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 500 502 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 520 522 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 584 586 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 869 871 828 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 902 905 861 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23F</sup>
###xml 1027 1029 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1174 1176 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1272 1273 1231 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1378 1380 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1597 1599 1556 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
The PCRs were carried out in a standard PCR mixture of 50 mul containing 2.5 mM of MgCl2, 240 muM (each) of deoxynucleoside triphosphates (dNTPs), 0.3 muM of each primer, and 2 U of Taq DNA polymerase (AmpliTaq Gold(R), Roche). The cycle conditions consisted of: an initial 94degreesC (10 min), 30 cycles of 94degreesC (1 min), 55degreesC (1 min) and 72degreesC (3 min), followed by 72degreesC (10 min). A multiplex PCR reaction was tested [32], but some samples did not amplify with LSM12/SKH63 [32,33] or LSM12/SKH52 [22] primer combinations. The combination of LSM12/SKH2 primers [16] was successfully used for all samples except one. The isolate that did not amplify was retested with the same cycle pattern at an annealing temperature of 52degreesC and with different primer combinations (LSM12/SKH63, LSM12/SKH52 and LSM12/SKH2). Controls for PspA family 1 (Spain14-ST18) and PspA family 2 (Spain23F-ST81) were run in each reaction set. PCR products were purified and sequenced using SKH2 primer, as described elsewhere [34]. Sequence edition was performed using the SeqScape version 2.1.1 (Applied Biosystems) software, while DNA sequences were assigned using BLAST [35]. Clade type was established when the closest match presented identity higher than 95% (Figure 1). The phylogenetic and molecular evolutionary analyses were conducted using MEGA4 version 4.1 software [36]. The evolutionary history was inferred using the Neighbor-Joining method and the bootstrap consensus tree inferred from 1000 replicates. The evolutionary distances were computed using the Kimura 2-parameter method [36].
###end p 23
###begin p 24
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psp</italic>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phylogenetic tree of a 373-bp region that includes <italic>psp</italic>A clade-defining region</bold>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
Phylogenetic tree of a 373-bp region that includes pspA clade-defining region. Phylogenetic and molecular evolutionary analyses were conducted with the MEGA4 program (version 4.1) [36] by the Neighbor-Joining method. Only bootstrap confidence intervals exceeding 90% are shown.
###end p 24
###begin title 25
Nucleotide sequence accession numbers
###end title 25
###begin p 26
The sequences of 27 isolates representing all the different sequences from this collection were deposited in GenBank with accession numbers: [GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:, GenBank:].
###end p 26
###begin title 27
Results and discussion
###end title 27
###begin title 28
PspA families and clade distribution
###end title 28
###begin p 29
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
Among the 112 pneumococci studied, the majority (59.8%, 67/112) were identified as belonging to PspA family 2 (31 isolates of clade 3, 27 of clade 4 and nine of clade 5), while the remaining 39.3% (44/112) belonged to family 1 (29 isolates of clade 1 and 15 of clade 2). One strain was negative. No PspA family 3 isolates were detected. Figure 1 shows the phylogenetic tree of the 27 new PspA sequences found as well as the accession numbers and the percentage of identity to previously published sequences. Sequences of strains of PspA families 1 and 2 were precisely grouped, and all were joined into their respective clades. The similarity of isolates of the same family ranged from 84% to 100%. The percentage of similarity within isolates of the same clade ranged as follows: clade 1 (84 to 95), clade 2 (84 to 100), clade 3 (93 to 99), clade 4 (91 to 98) and clade 5 (96 to 100).
###end p 29
###begin p 30
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 675 683 <span type="species:ncbi:9606">children</span>
Among the 66 pneumococci isolated from patients with IPD, 63,6% (42/66) were found to be of PspA family 2 (24 isolates of clade 3, 12 of clade 4 and six of clade 5), 34.8% (23/66) of family 1 (20 isolates of clade 1 and three of clade 2) and one isolate was negative. The high prevalence of PspA family 2 among pneumococci isolated from adults with IPD has already been reported in Spain, Canada, Sweden, the USA and France [37,38], although in Australia, the UK and Japan PspA family 1 was the most prevalent [38,39]. The dominance of family 2, clade 3 observed in our study has also been reported in other studies of pneumococci causing IPD in adults in France [37] and in children from Germany [40].
###end p 30
###begin p 31
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 106 114 <span type="species:ncbi:9606">children</span>
###xml 407 415 <span type="species:ncbi:9606">children</span>
###xml 641 649 <span type="species:ncbi:9606">children</span>
PspA family 2 was also dominant (54.3%, 25/46) among pneumococci isolated from the nasopharynx of healthy children (seven of clade 3, 15 of clade 4 and three of clade 5), while family 1 accounted for 45.7% (21/46) of the strains (nine of clade 1 and 12 of clade 2). These data are in agreement with two PspA studies [32,34] which found PspA family 2 to be dominant among pneumococci isolated from Brazilian children carriers. Moreover, the clade distribution also showed a prevalence of clade 4, followed by clade 1 and clade 3 [34]. A recent publication with data collected from pneumococci isolated from nasopharyngeal carriage in Finnish children showed similar prevalences of PspA family 1 and family 2 [41].
###end p 31
###begin p 32
###xml 16 17 16 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 210 218 <span type="species:ncbi:9606">children</span>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
Additional file 1 shows the results for PspA family and clade of the 112 pneumococcal isolates studied with respect to sequence type (ST), serotype, resistance pattern and source. The pneumococci isolated from children carriers or from patients with IPD invasive disease seem to be indistinct, suggesting that PspA type is independent of age or clinical origin, as has been shown elsewhere [32,34].
###end p 32
###begin title 33
Relationship between PspA and serotypes
###end title 33
###begin p 34
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 42 44 42 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 745 753 <span type="species:ncbi:9606">children</span>
In agreement with previous studies [16,32,42] our results showed that PspA clades are independent of serotypes. Pneumococci of the same serotype were associated with different PspA clades from the same or a different family (Additional file 1). For instance, pneumococci of serotype 6A could have PspA clade 2 (family 1), whereas pneumococci of serotype 6B could express PspA clades 1, 2, 4 or 5 (families 1 and 2). Since PspA is independent of serotype, PspA-based vaccines could improve upon the results obtained with serotype-based vaccines and might avoid a possible serotype replacement, as previously observed [10]. Since a PspA-based vaccine potentially has high coverage due to the fact that it is cross protective and immunogenic among children and adults [21], similar data should be investigated in other geographical areas in order to study the potential coverage of a PspA-based vaccine, and to adapt it to different formulations if necessary.
###end p 34
###begin title 35
Relationship between PspA and clones
###end title 35
###begin p 36
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psp</italic>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
PspA clade classification was related to genotypes, and all strains with the same ST always presented the same PspA clade (see Additional file 1), regardless of origin or capsular type. In spite of the high genetical variability of pspA gene, all isolates of the same ST showed 100% of identity between their sequences. For instance, among nine pneumococci with ST63 obtained from invasive and carriage samples, four capsular types were found (15A, 19A, 19F and 23F) but all of them had PspA of clade 4 (see Additional file 1). However, other authors have found different PspA families among isolates that shared a common ST [41]. In our study, among 65 STs found, only 7 accounted for more than three isolates (ST63 n = 9, ST156 n = 5, and ST42, ST260, ST180, ST62 and ST81 with four isolates each). This fact may be a limitation of the present study and may affect its capacity to assess the relationship between ST and PspA.
###end p 36
###begin p 37
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
The eBURST analysis reveals the presence of 15 clonal complexes (CC) and 22 singletons (S) (Additional file 1). The association of CC and S with clade was as follows: clade 1 (23 STs: 7 CC and 7 S), clade 2 (11 STs: 4 CC and 2 S), clade 3 (14 STs: 3 CC and 6 S), clade 4 (13 STs: 4 CC and 4 S), and clade 5 (4 STs: 1 CC and 3 S). Four CCs contained only clade 1-associated STs, three CCs contained clade 4-related STs, two CCs contained only clade 2-related STs, and two CC contained clade 3-related STs. Four CCs contained STs related to two different clades of the same or a different PspA family.
###end p 37
###begin p 38
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 317 319 317 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9V</sup>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 712 714 712 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6B</sup>
###xml 736 738 736 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 762 764 762 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23F</sup>
###xml 813 815 813 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">21</sup>
###xml 842 845 842 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15A</sup>
###xml 903 906 903 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23F</sup>
###xml 1139 1141 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
The relationship of PspA clade with multiresistant worldwide-disseminated clones described by the Pneumococcal Molecular Epidemiology Network (PMEN) [24] has been reported previously [32,42-44]. Our study provides further information since the majority of CCs found are related to PMEN clones. For instance, the Spain9V-ST156 (CC156) clone, which is one of the most important clones causing IPD worldwide [11,32,42,43], included six STs in the present study. All six STs of this CC had PspA clade 3, suggesting that PspA is highly conserved in this clone, even in SLV or DLV or when expressing capsular type 9 V or 14. Similar results were found among other CCs related to other multiresistant PMEN clones: Spain6B-ST90 (clade 1), Spain14-ST18 (clade 1), Denmark14-ST230 (clade 1), Spain23F-ST81 (clade 3), Greece21-ST193 (clade 4) and Sweden15A-ST63 (clade 4). The CC439 related to PMEN clone Tennessee23F-ST37, which included six STs in our study, had two PspA clades (1 and 4). This finding was in agreement with a study from Finland, which found PspA from families 1 and 2 among isolates within the same or different ST of this CC439 [41].
###end p 38
###begin p 39
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 714 715 714 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 732 733 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 765 767 765 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7F</sup>
###xml 786 787 786 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 807 809 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1007 1008 1007 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 607 615 <span type="species:ncbi:9606">children</span>
There is still little information about the relationship between PspA clade and antibiotic-susceptible PMEN clones, since the available data only refer to family level [42]. Our study provides new information about the antibiotic-susceptible clones, which are associated with the increase of IPD observed in recent years in some European countries [11,45] and in the USA [10]. For instance, the Sweden1-ST306 clone had clade 1. This clone has been described as the cause of IPD outbreaks in Europe and its frequency is currently increasing in Spain as cause of IPD and, especially, parapneumonic empyema in children [45]. CCs which were also related to antibiotic-susceptible PMEN clones included clade 1 (Colombia5-ST289 and Sweden1-ST304) and clade 3 (Netherlands7F-ST191, Netherlands3-ST180 and Tennessee14-ST67). Other associations of PspA clade with emerging clones were also observed such as clade 1 for serotype 22-ST433 and serotype 10A-CC97, and clade 5 for serotype 12-ST989. The CC53 (Netherlands8-ST53) included strains of two clades: clade 1 for those isolated with ST53 that were serotype 8, and clade 3 for isolates with ST62 (DLV) that were serotype 11A or non-typeable.
###end p 39
###begin p 40
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 399 407 <span type="species:ncbi:9606">children</span>
Since PspA type is associated with genotype, and with our knowledge of the clonal distribution of pneumococci causing IPD in Southern Barcelona area [11] we estimate that at least 45.1% would be of PspA family 2, and 23.4% of family 1. The most prevalent clades among invasive pneumococci would be clade 3 (48.2%) and clade 1 (33.7%). Similarly, we estimate that among the pneumococci isolated from children carriage [23] at least 31.6% appear to be PspA family 2 and 29.8% PspA family 1, with clade 3 (26.0%) and clade 1 (22.5%) being the most frequent.
###end p 40
###begin title 41
Conclusion
###end title 41
###begin p 42
###xml 34 36 34 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 37 39 37 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
Our study supports previous data [34,38,39,43] demonstrating that PspA family and clade distribution are independent of serotype, age and clinical origin of the isolates, but are highly associated with genotype. This study suggests that PspA family 1 and 2 molecules should be included in future PspA-based vaccine formulations. Further studies are needed to determine the genetic diversity of PspA in each geographical area.
###end p 42
###begin title 43
Authors' contributions
###end title 43
###begin p 44
CA and JL conceived the study and participated in its design. AF, RM and JL participated in field and clinical aspects of the study. DR and CA carried out the molecular genetic studies and sequence alignment. DR and CA wrote the manuscript, which was coordinated and critically reviewed by JL. All authors read and approved the final manuscript.
###end p 44
###begin title 45
Supplementary Material
###end title 45
###begin title 46
Additional File 1
###end title 46
###begin p 47
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
Table 1. Characteristics of 112 representative pneumococcal strains selected for this study.
###end p 47
###begin p 48
Click here for file
###end p 48
###begin title 49
Acknowledgements
###end title 49
###begin p 50
###xml 677 702 677 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 677 701 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
DR was supported by a grant from IDIBELL (Institut d'Investigacio Biomedica de Bellvitge). This work was supported by a grant from the Fondo de Investigaciones Sanitarias de la Seguridad Social (PI060647), and by CIBER de Enfermedades Respiratorias (CIBERES - CB06/06/0037), which is an initiative of the ISCIII - Instituto de Salud Carlos III, Madrid, Spain. We thank Dr. Adela G. de la Campa who offered critical review and helpful discussions. We are also grateful to our colleagues L. Calatayud, M. Alegre, E. Perez and all staff of the Microbiology Laboratory of the Hospital Universitari de Bellvitge for their assistance with this project. We acknowledge the use of the Streptococcus pneumoniae MLST website [29], which is located at Imperial College London and is funded by the Wellcome Trust.
###end p 50
###begin article-title 51
###xml 21 45 21 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 21 45 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment
###end article-title 51
###begin article-title 52
###xml 44 69 44 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 44 68 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 88 96 <span type="species:ncbi:9606">children</span>
Natural history of drug-resistant clones of Streptococcus pneumoniae colonizing healthy children in Portugal
###end article-title 52
###begin article-title 53
The enduring pneumococcus: unfinished business and opportunities for the future
###end article-title 53
###begin article-title 54
###xml 63 87 63 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 63 87 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Discovery of a new capsular serotyp (6C) within serogroup 6 of Streptococcus pneumoniae
###end article-title 54
###begin article-title 55
Pneumococcal vaccines: an update on current strategies
###end article-title 55
###begin article-title 56
Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence
###end article-title 56
###begin article-title 57
Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study
###end article-title 57
###begin article-title 58
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
###end article-title 58
###begin article-title 59
###xml 79 103 79 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 79 103 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae
###end article-title 59
###begin article-title 60
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004
###end article-title 60
###begin article-title 61
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007
###end article-title 61
###begin article-title 62
Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine
###end article-title 62
###begin article-title 63
Protein Vaccines
###end article-title 63
###begin article-title 64
###xml 110 134 110 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 110 134 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae
###end article-title 64
###begin article-title 65
###xml 131 155 131 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 131 155 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae
###end article-title 65
###begin article-title 66
###xml 71 94 71 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococus pneumoniae</italic>
Diversity of PspA: Mosaic genes and evidence for past recombination in Streptococus pneumoniae
###end article-title 66
###begin article-title 67
Pneumococcal virulence factors: structure and function
###end article-title 67
###begin article-title 68
###xml 27 51 27 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 27 51 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type
###end article-title 68
###begin article-title 69
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA)
###end article-title 69
###begin article-title 70
Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades
###end article-title 70
###begin article-title 71
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules
###end article-title 71
###begin article-title 72
###xml 43 68 43 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 43 67 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 92 100 <span type="species:ncbi:9606">children</span>
Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children
###end article-title 72
###begin article-title 73
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 0 24 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 44 52 <span type="species:ncbi:9606">children</span>
Streptococcus pneumoniae colonizing healthy children attending Day Care Centers (DCCs): two years of annual surveillance
###end article-title 73
###begin article-title 74
###xml 56 81 56 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 56 80 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network
###end article-title 74
###begin article-title 75
###xml 13 39 13 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae: </italic>
###xml 13 37 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Evolution of Streptococcus pneumoniae: serotypes and antibiotic resistance in Spain. Update 1990-1996
###end article-title 75
###begin article-title 76
###xml 40 64 40 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 40 64 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease
###end article-title 76
###begin article-title 77
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 0 24 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Streptococcus pneumoniae MLST database
###end article-title 77
###begin article-title 78
eBURST: Inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data
###end article-title 78
###begin article-title 79
eBURST Website
###end article-title 79
###begin article-title 80
###xml 51 76 51 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 51 75 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: towards novel pneumococcal protein vaccines
###end article-title 80
###begin article-title 81
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psp </italic>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psp</italic>
###xml 93 117 93 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 93 117 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Oligonucleotides identify conserved and variable regions of psp A and pspA-like sequences of Streptococcus pneumoniae
###end article-title 81
###begin article-title 82
###xml 112 120 <span type="species:ncbi:9606">children</span>
Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil
###end article-title 82
###begin article-title 83
Basic Local Alignment Search Tool Website
###end article-title 83
###begin article-title 84
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0
###end article-title 84
###begin article-title 85
Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease
###end article-title 85
###begin article-title 86
Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries
###end article-title 86
###begin article-title 87
###xml 47 72 47 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 47 71 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Pneumococcal surface protein A family types of Streptococcus pneumoniae from community-acquired pneumonia patients in Japan
###end article-title 87
###begin article-title 88
###xml 55 80 55 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 55 79 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 101 109 <span type="species:ncbi:9606">children</span>
Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children
###end article-title 88
###begin article-title 89
###xml 70 95 70 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 70 94 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 109 117 <span type="species:ncbi:9606">children</span>
Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in Finland who had acute otitis media or were nasopharyngeal carriers
###end article-title 89
###begin article-title 90
###xml 82 107 82 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae </italic>
###xml 82 106 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 132 140 <span type="species:ncbi:9606">patients</span>
Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland
###end article-title 90
###begin article-title 91
Pneumococcal PspA sequence types of prevalent pneumococcal strains in the United States and of internationally disseminated clones
###end article-title 91
###begin article-title 92
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Genotypes of invasive pneumococcal isolates recently recovered from Italian patients
###end article-title 92
###begin article-title 93
Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study
###end article-title 93

